Candel Therapeutics (CADL) Assets: 2020-2022
Historic Assets for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $77.7 million.
- Candel Therapeutics' Assets fell 41.11% to $50.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $50.1 million, marking a year-over-year decrease of 41.11%. This contributed to the annual value of $77.7 million for FY2022, which is 12.91% down from last year.
- According to the latest figures from FY2022, Candel Therapeutics' Assets is $77.7 million, which was down 12.91% from $89.2 million recorded in FY2021.
- Candel Therapeutics' 5-year Assets high stood at $89.2 million for FY2021, and its period low was $38.3 million during FY2020.
- In the last 3 years, Candel Therapeutics' Assets had a median value of $77.7 million in 2022 and averaged $68.4 million.
- Per our database at Business Quant, Candel Therapeutics' Assets spiked by 133.02% in 2021 and then fell by 12.91% in 2022.
- Yearly analysis of 3 years shows Candel Therapeutics' Assets stood at $38.3 million in 2020, then skyrocketed by 133.02% to $89.2 million in 2021, then dropped by 12.91% to $77.7 million in 2022.